Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/12/25 17:12 | 2/11/25 | BDSX | Health | Health | Medical Laboratories | Vazquez Chris | CO | O | Chief Ac | 5 | S.dm | -8 | 1.26 | 0 | -6 | 18 | D | |||||||||||||||
2/12/25 17:12 | 2/11/25 | BDSX | Health | Health | Medical Laboratories | Pestano Gary Anthony | CO | O | Chief De | 5 | S.dm | -37 | 1.28 | 0 | -29 | 156 | D | |||||||||||||||
2/12/25 17:11 | 2/11/25 | BDSX | Health | Health | Medical Laboratories | O'Kane Kieran | CO | O | Chief Co | 5 | S.dm | -39 | 1.29 | 0 | -31 | 128 | D | |||||||||||||||
2/12/25 17:11 | 2/11/25 | BDSX | Health | Health | Medical Laboratories | Hutton Scott | CO | DO | P,CEO | 5 | S.dm | -210 | 1.32 | 0 | -159 | 702 | D | |||||||||||||||
2/12/25 17:11 | 2/11/25 | BDSX | Health | Health | Medical Laboratories | Cowie Robin Harper | CO | O | CFO,Sec' | 5 | S.dm | -61 | 1.32 | 0 | -46 | 246 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |